Bevacizumab (Avegra®) for the treatment of gynecological cancers: joint experience of several centers

• Κύριοι συγγραφείς: A. G. Kedrova (Συγγραφέας), S. Е. Krasilnikov (Συγγραφέας), D. S. Ogay (Συγγραφέας), Т. A. Maksimenko (Συγγραφέας), V. I. Voznesenskiy (Συγγραφέας), А. I. Berishvili (Συγγραφέας), Т. A. Greyan (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: ABV-press, 2021-03-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Tumors of the female reproductive system are among the five most common cancers in women worldwide. Up to 60 % of these patients require chemotherapy to reduce the risk of recurrence. Currently, an additional treatment option is available for patients with advanced cancers of the female reproductive...